IS RENAL IMPAIRMENT CONCEALED IN ELDERLY DIABETICS????
DOI:
https://doi.org/10.22159/ijpps.2016v8i12.14887Keywords:
Diabetes Mellitus, Creatinine clearance, Younger diabeticsAbstract
Objective: To compare and evaluate the renal profile of elderly and younger diabetics.
Methods: This cross sectional study was conducted in a tertiary care teaching hospital. Patients with type-2-diabetes were grouped into elderly (age≥60years) and younger diabetics. Patients' demographics, duration of diabetes and serum creatinine were recorded. Cockcroft-Gault formula was used to calculate creatinine clearance (Clcr). Statistical analysis was done using Students'‘t' test and Pearson's correlation. Regression analysis to adjust for covariables was done wherever required.
Results: A total of 477 diabetics were included (elderly n=320, young n=157). Body mass index (BMI) was significantly lower (p=0.003) and duration of diabetes was significantly longer (p=0.001) among elderly. Significant difference was noted in serum creatinine (1.06±0.32 vs 0.95±0.29 mg/dl; p=0.0002) and Clcr (57.82±17.41 vs 88.07±24.60 ml/min; p=0.001) between elderly and younger diabetics. Only 4.7% of elderly, whereas 47.8% of young had normal Clcr. Clcr showed a negative correlation with age in elderly (r=-0.389, p<0.001) and young (r=-0.396, p<0.001) and positive correlation with BMI in elderly (r=0.401, p<0.001) and young(r=0.337, p<0.001). Regression analysis of Clcr in elderly and young showed a positive correlation for BMI and inverse relationship for age and duration of diabetes mellitus.
Conclusion: Almost 95% of the elderly and 50% of younger diabetics had impaired creatinine clearance. Renal impairment was concealed in most of them since mean serum creatinine was 1 mg/dl. Indian elderly diabetics should be considered renally impaired and drugs for all conditions need adjustment for creatinine clearance.
Downloads
References
Pradeepa R, Mohan V. The changing scenario of the diabetes epidemic: implication for India. Indian J Med Res 2002;116:121-32.
Meneilly GS, Tressier D. Diabetes in elderly adults. J Gerontol Ser A 2001;56:M5-13.
Rosenstock J. Management of type 2 diabetes mellitus in the elderly: special considerations. Drugs Aging 2001;18:31-44.
Blickle JF, Doucet J, Krummel T, Hannedouch T. Diabetic nephropathy in the elderly. Diabetes Metab 2007;33:S40-55.
McGowan T, McCue P, Sharma K. Diabetic nephropathy. Clin Lab Med 2001;21:111-46.
Osterby R. Early phases in the development of diabetic glomerulopathy. Acta Med Scand 1975;574 Suppl:1-80.
Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC. Structural-functional relationships in diabetic nephropathy. J Clin Invest 1984;74:1143-55.
DeJong PE, Hillege HL, Pinto Sietsma SJ, DeZeeuw D. Screening for microalbuminuria in the general population: a tool to detect subjects at risk for progressive renal failure in an early phase? Nephrol Dial Transplant 2003;18:10-3.
Lindeman RD. Assessment of renal function in the old. Special consideration. Clin Lab Med 1993;13:269-77.
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
Muhlberg W, Platt D. Age-dependent changes of the kidney: pharmacological implications. Gerontology 1999;45:243-53.
National Kidney Foundation-K/DOQI. Clinical Practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 2002;39:S1-266.
Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32:112-9.
Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Klag MJ, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National kidney foundation task force on cardiovascular diseases. Am J Kidney Dis 1998;32:853-905.
Bakris GL, Williams M, Dworkin L, Elliot WJ, Epstein M, Toto RDA, et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000;36:646-61.
Agarwal SK, Dash SC. Spectrum of renal disease in Indian adults. J Assoc Physicians India 2000;48:594-600.
Poonguzhali DV, Vinodhini VM, Ebenezer William, Kumar JS. Evaluation of apolipoprotein-B levels in dysglycemia. Asian J Pharm Clin Res 2013;6:112-4.
Chau D, Edelman SV. Clinical management of diabetes in the elderly. Clin Diabetes 2001;19:172-5.
Mooradian AD, McLaughlin S, Boyere CC, Winter J. Diabetes care for older adults. Diabetes Spectrum 1999;12:70-7.
Kyrou I, Tsigos C. Obesity in the elderly diabetic patients. Diabetes Care 2009;32:S403-9.
Corsonello A, Pedone C, Corica F, Mussi C, Carbonin P, Antonelli Incalzi R. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med 2005;165:790-5.
Kurtal H, Schwenger V, Azzaro M, Abdollahnia N, Steinhagen-Thiessen E, Nieczaj R, et al. Clinical value of automatic reporting of estimated glomerular filtration rate in geriatrics. Gerontology 2009;55:288-95.
Wasen E, Isoaho R, Mattila K, Vahlberg T, Kivela SL, Irjala K. Estimation of glomerular filtration rate in the elderly: a comparison of creatinine based formulae with serum cystatin C. J Intern Med 2004;256:70-8.
Sudhakar P, Sivakumar V, Sabhapathi D. The creatinine clearance in the elderly. Indian J Urol 2000;17:69-70.
Published
How to Cite
Issue
Section
